Independent site. Not an official website of the Northern Ireland Assembly. Find out more
Asked by Paula

AQW 818/22-27 Written question to the Minister of Health

To ask the Minister of Health for an update when the commencement of the trialling of Kuvan on patients in Northern Ireland will take place.

Asked by Paula Bradshaw MLA on 31 May 2022

  • Answered
  • Written
Tabled
31 May 2022
Answer due by
17 June 2022
Answered
7 June 20227 days after tabling
Department
Department of Health
Priority question
No

Answer

My Department has a formal link with NICE under which NICE Technology Appraisals are reviewed locally for their legal and policy applicability here, and where found to be applicable, they are endorsed for implementation within Health and Social Care (HSC).

I can advise that Sapropterin (Kuvan) for treating hyperphenylalaninaemia in phenylketonuria was endorsed by my Department on 20 October 2021 and is available in Northern Ireland in line with the current NICE guidelines (TA729). Further information on the guidance is available from:

https://www.nice.org.uk/guidance/ta729

Official sources

  • AQW 55043/22-27To ask the Minister of Health to detail any current plans for additional drug rehabilitation provision within the Belfast Health and Soci…
  • AQW 52948/22-27To ask the Minister of Health to detail any steps being taken to address staffing levels in Emergency Departments, particularly overnight…
  • AQW 52947/22-27To ask the Minister of Health to detail any steps being taken in Emergency Departments to prevent blood results and other important patie…
  • AQW 52946/22-27To ask the Minister of Health to detail any changes being considered to ensure that patients waiting for service in Emergency Departments…
  • AQW 52945/22-27To ask the Minister of Health to detail any long-term plans in place to improve Emergency Department capacity and reduce prolonged waits.